By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Jun 25, 2025/Report (Open Access)
APTA’s "State of Direct Access to Physical Therapist Services" report is a strategic resource designed to equip health care leaders with the scientific evidence they need to address opposition to direct access and drive meaningful change.
Nov 25, 2025/Podcast
Listening Time — 18:30 Listen on Apple Listen on Castbox Listen on Spotify In this episode, APTA staff experts Rachel Miller, MPH, and Sharon West, JD, discuss how the final 2026 Medicare Physician Fee Schedule will affect the physical therapy profession. They explain why physical therapists can expect
Jan 21, 2023/CPG
Exercise-Based Knee and Anterior Cruciate Ligament Injury Prevention
Aug 27, 2021/Podcast
PTJ Editor-in-Chief Alan Jette, PT, PhD, FAPTA, talks with Kathleen Mangione, PT, PhD, FAPTA, about something critically important to physical therapists but rarely top of mind: treatment fidelity.
May 16, 2019/Test & Measure
This survey was developed as a relevant short version of the Knee Injury and Osteoarthritis Outcome (KOOS) for a specific population.
Oct 5, 2021/Perspective
"I have made it my mission in life to spend my time honoring our nation's veterans, service members, and their families."
Feb 25, 2020/Perspective
In an effort to get everyone on the same page, I'm debunking some of the most prevalent Medicare myths I've been seeing lately on social media and in other venues.
Nov 30, 2017/Test & Measure
Used for patients with suspected delirium.
Sep 27, 2021/Podcast
PTJ talks with Pamela Dunlap about fear-avoidance beliefs and how measurement of those beliefs can help clinicians identify people at a greater risk of disability after vestibular disorder.
Jul 12, 2021/Test & Measure
The Harris Infant Neuromotor Test (HINT) is a screening tool designed to identify neuromotor or cognitive/behavioral concerns in infants who are healthy or at high risk between the ages of 3 and 12 months.
